✦ LIBER ✦

Weekly dose of leflunomide for the treatment of refractory rheumatoid arthritis: an open pilot comparative study

✍ Scribed by Juan Jakez-Ocampo; Yvonne Richaud-Patin; J Abraham Simón; Luis Llorente

Book ID: 114371211
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 126 KB
Volume: 69
Category: Article
ISSN: 1297-319X
DOI: 10.1016/s1297-319x(02)00397-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Leflunomide in the treatment of rheumato

Leflunomide in the treatment of rheumatoid arthritis. An analysis of predictors for treatment continuation

✍ E. N. Van Roon; M. Hoekstra; H. Tobi; T. L. TH. A. Jansen; H. J. Bernelot Moens; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Induction therapy with an intravenous lo

Induction therapy with an intravenous loading dose of azathioprine for treatment of refractory, active rheumatoid arthritis

✍ Eric L. Matteson; Carlos H. Orces; Joseph Duffy; James J. Lipsky; M. Gennett Pik 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

Induction therapy with an intravenous loading dose of azathioprine for treatment of refractory

Comparative assessment of leflunomide an

Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging

✍ Richard J. Reece; Maarten C. Kraan; Aleksandra Radjenovic; Douglas J. Veale; P. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 843 KB

Extracorporeal photopheresis for the tre

Extracorporeal photopheresis for the treatment of refractory Crohn's disease: Results of an open-label pilot study

✍ Maria T. Abreu; Christian von Tirpitz; Robert Hardi; Martin Kaatz; Gert Van Assc 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB 👁 2 views

## Background: Extracorporeal photopheresis (ecp) is effective in immune-mediated disorders. a prospective, uncontrolled pilot study was conducted to evaluate the safety and efficacy of ecp in patients with active crohn's disease (cd) who were refractory to or intolerant of immunosuppressants and/o

PAR19 COMPARISON OF ORAL LEFLUNOMIDE AND

PAR19 COMPARISON OF ORAL LEFLUNOMIDE AND METOTREXATE SC FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: AN APPROACH BASED ONTHE NUMBERTOTREAT

✍ A García Ruiz; L Betegon; A Echevarria 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Masitinib in the treatment of active rhe

Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study

✍ Jacques Tebib, Xavier Mariette, Pierre Bourgeois… 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 152 KB